Related Experiment Videos
[LDL receptor gene analysis and phenotypic variation of familial hypercholesterolemia]
1Department of Internal Medicine, Aoto Hospital, School of Medicine, Jikei University.
Insights
Familial hypercholesterolemia, a common genetic disease, results from LDL receptor gene defects. Understanding mutation types and other factors is key to explaining clinical variations and improving treatment.
Area of Science:
- Genetics
- Molecular Biology
- Cardiovascular Disease
Context:
- Familial hypercholesterolemia (FH) is a prevalent single-gene disorder.
- It stems from impaired low-density lipoprotein (LDL) catabolism, leading to elevated plasma cholesterol.
- This results in cholesterol deposition in arteries and premature coronary artery disease (CAD).
Purpose:
- To investigate the genetic basis of clinical variability in familial hypercholesterolemia.
- To explore the role of LDL receptor gene mutations in FH phenotypes.
- To identify additional genetic and environmental factors influencing FH severity and treatment response.
Summary:
- FH is caused by inherited defects in the LDL receptor gene.
- The specific nature of LDL receptor gene mutations correlates with clinical variability.
- Other genetic factors (e.g., apo E, apo B) and environmental influences may also contribute to FH presentation and treatment outcomes.
Impact:
- Highlights the importance of LDL receptor gene mutation analysis for understanding FH.
- Suggests a multifactorial etiology for FH clinical diversity.
- Underscores the need for advanced molecular techniques (e.g., knock-out, transgenic models) to further elucidate FH pathogenesis and develop novel therapies.
Abstract:
Familial hypercholesterolemia, one of the most common single-gene disease in which defective catabolism of LDL is responsible for the increased plasma cholesterol and leads to the deposition of cholesterol in the arterial wall and premature coronary artery disease, is caused by inherited defects in the gene for the low density lipoprotein receptor. Clinical variation is known to exist in familial hypercholesterolemia. Since cloning of the human LDL receptor gene, it has been revealed that the nature of the LDL receptor gene mutation contributes to these clinical variability of familial hypercholesterolemia. Other mutations not linked to LDL receptor gene, such as apo E, apo B and several growth factor genes, and environmental factors may also be related to the severity of symptom or response to the treatment in familial hypercholesterolemia. Further study in the molecular biological field using knock-out and transgenic expression techniques is needed to elucidate the key factors which influence the clinical varieties of expression in familial hypercholesterolemia and to develop the new methods for treatment.